ABVC BioPharma, Inc. Proceeds from Issuance of Warrants
ABVC BioPharma, Inc. (ABVC) reported Proceeds from Issuance of Warrants of $83.57 thousand for the 1-month period ending 2025-07-31, per its 10-Q filed 2026-05-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-05-18
- ABVC BioPharma, Inc. proceeds from issuance of warrants for the quarter ending 2024-12-31 was $0.00.
- ABVC BioPharma, Inc. proceeds from issuance of warrants for the quarter ending 2024-09-30 was $0.00.
- ABVC BioPharma, Inc. proceeds from issuance of warrants for the quarter ending 2024-06-30 was $0.00.
- ABVC BioPharma, Inc. proceeds from issuance of warrants for the quarter ending 2024-03-31 was $394.07K.
- ABVC BioPharma, Inc. proceeds from issuance of warrants for fiscal 2024 was $394.07K, a 83.62% decline from fiscal 2023.
- ABVC BioPharma, Inc. proceeds from issuance of warrants for fiscal 2023 was $2.41M.
| Period end | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|
| 2025-07-31 | $83.57K 10-Q · filed 2026-05-18 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $0.00 derived: sum of 3 quarters · filed 2026-03-03 | $394.07K 10-K · filed 2026-03-03 | |
| 2024-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $394.07K 10-Q/A · filed 2026-03-03 | $371.38K derived: sum of 4 quarters · filed 2026-03-03 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $394.07K 10-Q · filed 2025-08-13 | $371.38K derived: sum of 3 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $394.07K 10-Q · filed 2025-04-30 | $371.38K derived: sum of 2 quarters · filed 2025-04-30 | |||
| 2023-12-31 | -$22.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $2.41M 10-K · filed 2025-04-15 | |||
| 2023-09-30 | $2.43M 10-Q · filed 2024-11-14 |